Cumberland Pharmaceu (CPIX) Stock Price, Quote & News

Company Profile

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy tr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 615 255 0068

Fax: 615 255 0094

Website: www.cumberlandpharma.com

Address:

1600 West End Avenue, Suite 1300, Nashville, United States

topstockalerts Jul. 15 at 5:21 PM

$CPIX today’s strongest move might not be the loudest one.

0 · Reply

rabbitsoup Jul. 15 at 4:45 PM

$CPIX There were only about 240k shares short as of 6/30. I assume most have covered or will cover or they are required to pay the dividend.

0 · Reply

Endlessall Jul. 15 at 3:04 PM

$CPIX Management is so important. I was in $ESPR and by luck made a little money but the opportunity cost was big and not having management "aligned" with shareholders really sucked.

2 · Reply

vinland Jul. 15 at 2:43 PM

$CPIX good enough all out, maybe buy back around record date. GLTA

0 · Reply

haha1978 Jul. 15 at 2:24 PM

$CPIX we broke prior resistance and hit a new 52 week high and channel. The channel is 7.50 to 10 or 11. Should go to double digits. $XBI cant believe we are getting a special dividend ex dividend 7/23 of $1.50. $JEPQ

0 · Reply

Invest2live Jul. 14 at 7:02 PM

$CPIX 318% already; congrats 🔆🌷🌿 Checkout $AKBA and $RXRX

1 · Reply

vinland Jul. 14 at 5:49 PM

$CPIX heads up, since special div was announced when stock was under $6.00 on July 13, the div is a bit more than 25% of the stock price at time div was announced. As such, look for a PR clarifying the exdate to be Aug 3 and not July 23. Google >25% special dividends and due bills. GL!

0 · Reply

Fenderstrat68 Jul. 14 at 2:05 PM

$CPIX how is volume not going crazy!!? $1.50 dividend/share on July 23rd!! Basically paying $5 for an $8STOCK!Smh

3 · Reply

BioResearcher Jul. 14 at 12:58 PM

$CPIX Great company with awesome Management !

0 · Reply

haha1978 Jul. 14 at 12:55 PM

$CPIX @BioResearcher wow. Look they paid a $1.50 divident this month.

2 · Reply

Cumberland announces special dividend of $1.50 per share

2026-07-13T14:55:27.000Z - 2 days ago

Cumberland board authorizes $5M share repurchase program

Jul 13, 2026, 10:46 AM EDT - 2 days ago

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Jul 1, 2026, 9:00 AM EDT - 14 days ago

Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals

Jul 1, 2026, 9:00 AM EDT - 14 days ago

Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex

2026-06-26T15:05:14.000Z - 19 days ago

Cumberland shares updated FIGHT DMD trial results

Jun 26, 2026, 11:00 AM EDT - 19 days ago

Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference

Jun 22, 2026, 4:10 PM EDT - 22 days ago

RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement

RDHL

Jun 18, 2026, 8:00 AM EDT - 27 days ago

RedHill Biopharma Announces Up To $19.4 Million Private Placement

RDHL

Jun 9, 2026, 7:00 AM EDT - 5 weeks ago

RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation

RDHL

Jun 8, 2026, 7:00 AM EDT - 5 weeks ago

RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo

RDHL

2026-06-02T14:45:10.000Z - 6 weeks ago

Cumberland announces data from Phase 2a clinical trial of ifetroban

Jun 2, 2026, 9:05 AM EDT - 6 weeks ago

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis

Jun 2, 2026, 8:00 AM EDT - 6 weeks ago

RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms

RDHL

2026-05-28T14:51:26.000Z - 6 weeks ago

Cumberland announces launch of Vibativ in China

May 28, 2026, 9:05 AM EDT - 6 weeks ago

CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA

May 26, 2026, 8:00 AM EDT - 7 weeks ago

Cumberland Pharmaceuticals Proxy statement: Proxy filing

May 15, 2026, 8:00 AM EDT - 2 months ago

Cumberland Pharmaceuticals Proxy statement: Proxy filing

May 5, 2026, 5:00 PM EDT - 2 months ago

CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

May 5, 2026, 4:30 PM EDT - 2 months ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Cumberland Pharmaceuticals Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Cumberland Pharmaceuticals Quarterly report: Q1 2026

Apr 30, 2026, 7:00 AM EDT - 2 months ago

RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease

RDHL

Apr 28, 2026, 4:05 PM EDT - 2 months ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

Apr 27, 2026, 8:00 AM EDT - 2 months ago

RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights

RDHL

2026-04-23T13:13:38.000Z - 2 months ago

Cumberland announces transaction to integrate commercial business with Apotex

Apr 23, 2026, 9:00 AM EDT - 2 months ago

Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex

Apr 23, 2026, 8:00 AM EDT - 2 months ago

Cumberland Pharmaceuticals Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 3 months ago

RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026

RDHL

2026-04-16T13:58:04.000Z - 3 months ago

Cumberland receives FDA approval for expanded Caldolor injection

Apr 16, 2026, 9:05 AM EDT - 3 months ago

CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE

2026-03-17T13:21:41.000Z - 4 months ago

Cumberland announces launch of new Sancuso website

Mar 17, 2026, 9:05 AM EDT - 4 months ago

Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting

Mar 9, 2026, 8:00 AM EDT - 4 months ago

Cumberland Pharmaceuticals Proxy statement: Proxy Filing

Mar 9, 2026, 8:00 AM EDT - 4 months ago

Cumberland Pharmaceuticals Proxy statement: Proxy Filing

Mar 3, 2026, 5:00 PM EST - 4 months ago

CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH

Mar 3, 2026, 4:30 PM EST - 4 months ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 4:30 PM EST - 4 months ago

Cumberland Pharmaceuticals Annual report: Q4 2025

Mar 3, 2026, 4:30 PM EST - 4 months ago

Cumberland Pharmaceuticals Earnings release: Q4 2025

Mar 3, 2026, 4:30 PM EST - 4 months ago

Cumberland Pharmaceuticals Annual report: Q4 2025

2026-02-25T12:20:11.000Z - 5 months ago

Cumberland and THI announce U.S. commercialization of Talicia

2026-02-25T12:17:19.000Z - 5 months ago

RedHill Biopharma announces full sales and operational launch of Talicia

RDHL

Feb 25, 2026, 7:00 AM EST - 5 months ago

Joint U.S. Commercialization of RedHill's Talicia® Commences

RDHL

Feb 25, 2026, 7:00 AM EST - 5 months ago

CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®

Feb 24, 2026, 4:05 PM EST - 5 months ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE

2026-02-04T14:11:54.000Z - 5 months ago

Cumberland receives fast track designation for DMD oral therapy from FDA

Feb 4, 2026, 9:05 AM EST - 5 months ago

Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program

Dec 8, 2025, 9:05 AM EST - 7 months ago

CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT

Nov 4, 2025, 5:00 PM EST - 9 months ago

CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH

Nov 4, 2025, 4:30 PM EST - 9 months ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 9 months ago

Cumberland Pharmaceuticals Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 9 months ago

Cumberland Pharmaceuticals Earnings release: Q3 2025

Oct 28, 2025, 4:05 PM EDT - 9 months ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE

2025-10-20T13:05:16.000Z - 9 months ago

RedHill Biopharma signs strategic partnership with Cumberland

RDHL

Oct 20, 2025, 9:05 AM EDT - 9 months ago

CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO

RDHL

Oct 20, 2025, 9:00 AM EDT - 9 months ago

RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal

2025-10-13T13:10:36.000Z - 9 months ago

Cumberland adds Vibativ to national group purchasing agreement with Premier

Oct 13, 2025, 9:05 AM EDT - 9 months ago

CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.

2025-10-01T13:10:20.000Z - 10 months ago

Cumberland says ibuprofen injection product gets regulatory approval in Mexico

Oct 1, 2025, 9:05 AM EDT - 10 months ago

CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO

2025-09-29T13:10:14.000Z - 10 months ago

Cumberland announces launch of Vibativ injection in Saudi Arabia

Sep 29, 2025, 9:05 AM EDT - 10 months ago

TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Quarterly report: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Earnings release: Q2 2025

Aug 5, 2025, 4:05 PM EDT - 1 year ago

Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date

2025-08-04T13:10:32.000Z - 1 year ago

Cumberland announces availability of Vibativo 4-Vial Starter Pak through Vizient

Aug 4, 2025, 9:05 AM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK

Jul 29, 2025, 4:05 PM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE

2025-06-23T17:50:52.000Z - 1 year ago

Cumberland shares latest results from its Phase 2 FIGHT DMD trial

Jun 23, 2025, 9:05 AM EDT - 1 year ago

Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference

May 27, 2025, 4:05 PM EDT - 1 year ago

NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS

2025-05-13T20:22:40.000Z - 1 year ago

Cumberland announces partnership with Qureight

May 13, 2025, 4:05 PM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH

May 6, 2025, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Quarterly report: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Earnings release: Q1 2025

May 6, 2025, 4:05 PM EDT - 1 year ago

Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025

Apr 29, 2025, 4:05 PM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE

Mar 19, 2025, 4:05 PM EDT - 1 year ago

FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Cumberland Pharmaceuticals Proxy statement: Proxy Filing

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Cumberland Pharmaceuticals Proxy statement: Proxy Filing

Mar 4, 2025, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Annual report: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Earnings release: Q4 2024

Mar 4, 2025, 4:05 PM EST - 1 year ago

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth

Feb 25, 2025, 4:05 PM EST - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS

Feb 18, 2025, 7:30 AM EST - 1 year ago

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA

Feb 4, 2025, 7:30 AM EST - 1 year ago

Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease

Dec 9, 2024, 4:05 PM EST - 1 year ago

FDA APPROVES ACETADOTE® sNDA

Nov 7, 2024, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Earnings release: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update

Nov 6, 2024, 5:21 PM EST - 1 year ago

CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Nov 5, 2024, 4:05 PM EST - 1 year ago

New Study Compares Caldolor® (ibuprofen injection) to ketorolac

Oct 31, 2024, 4:05 PM EDT - 1 year ago

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS

topstockalerts Jul. 15 at 5:21 PM

$CPIX today’s strongest move might not be the loudest one.

0 · Reply

rabbitsoup Jul. 15 at 4:45 PM

$CPIX There were only about 240k shares short as of 6/30. I assume most have covered or will cover or they are required to pay the dividend.

0 · Reply

Endlessall Jul. 15 at 3:04 PM

$CPIX Management is so important. I was in $ESPR and by luck made a little money but the opportunity cost was big and not having management "aligned" with shareholders really sucked.

2 · Reply

vinland Jul. 15 at 2:43 PM

$CPIX good enough all out, maybe buy back around record date. GLTA

0 · Reply

haha1978 Jul. 15 at 2:24 PM

0 · Reply

Invest2live Jul. 14 at 7:02 PM

$CPIX 318% already; congrats 🔆🌷🌿 Checkout $AKBA and $RXRX

1 · Reply

vinland Jul. 14 at 5:49 PM

0 · Reply

Fenderstrat68 Jul. 14 at 2:05 PM

$CPIX how is volume not going crazy!!? $1.50 dividend/share on July 23rd!! Basically paying $5 for an $8STOCK!Smh

3 · Reply

BioResearcher Jul. 14 at 12:58 PM

$CPIX Great company with awesome Management !

0 · Reply

haha1978 Jul. 14 at 12:55 PM

$CPIX @BioResearcher wow. Look they paid a $1.50 divident this month.

2 · Reply

haha1978 Jul. 14 at 3:08 AM

$CPIX https://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-announces-special-dividend-of-1-50-per-share-302823903.html

0 · Reply

haha1978 Jul. 14 at 2:48 AM

$CPIX good to be im before the crowds. Scarity exist with that tight float.

1 · Reply

haha1978 Jul. 14 at 2:45 AM

$CPIX congratulations longs. Well deserved bonus money. Must be a partnership coming if they paid a special dividend and reauthorized a share buyback too. Best biotech out there.

0 · Reply

haha1978 Jul. 14 at 12:01 AM

$CPIX $XBI $IBB $QQQ dividend payable if in by july 23rd. Mistake on the initial pr.

0 · Reply

specialdividends Jul. 13 at 10:19 PM

$CPIX $1.50 special dividend, exdate july 23.

0 · Reply

biotechdollars Jul. 13 at 9:30 PM

$CPIX bullish news. lends confidence to a) dmd results b) possibility of an existing handshake agreement on partnership--possibly the cancer drug, in our view.

1 · Reply

frontiere Jul. 13 at 7:11 PM

$CPIX Cumberland ref=$5.94 — Long — the $1.50 special dividend is payable July 31 to shrholders of record July 👍 23 👍 Unbelievably local feed doesn’t have the Corrected announcement . 🤔 so net cost of shares is ~ $4.50 assuming mkt px same as now. Isn’t it a bullish long from there? https://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-announces-special-dividend-of-1-50-per-share-302823903.html

1 · Reply

Endlessall Jul. 13 at 4:19 PM

$CPIX I love this management team and the insider ownership and the focus.

0 · Reply

focafoca99 Jul. 13 at 4:19 PM

$CPIX confirms a special cash dividend of $1.50 per share, payable July 31 to shareholders of record July 10.

1 · Reply

LewisDaKat Jul. 13 at 4:00 PM

$CPIX CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE https://marketwirenews.com/stock/cpix/news/cumberland-pharmaceuticals-announces-special-dividen-5256737688560491.html?utm_source=stocktwits

0 · Reply

cmeola1066 Jul. 13 at 3:38 PM

$CPIX Interesting move by AJ. Free money...free bet.

1 · Reply

AlertsAndNews Jul. 13 at 2:49 PM

$CPIX div announcement here CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

1 · Reply

Market Cap	97.99M
Revenue (ttm)	44.52M
Net Income (ttm)	-2.84M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.38%
Debt to Equity Ratio	0.25

Volume	60,793
Avg Vol	109,048
Day's Range	N/A - N/A
Shares Out	14.98M
Stochastic %K	77%
Beta	0.09
Analysts	Strong Buy
Price Target	$8.50